Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
51 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Dr. Neveen Abdelazeem Abdelraheem 2022
52 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
53 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Dr. Noha gaber sayed 2022
54 Neutropenic Fever in Pediatric Patients with Cancer in South Egypt: A Report from a Single Institute Department of Pediatric Oncology Dr. Amira Mahmoud Mohammed Osman 2022
55 Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations Department of Anesthesia, Intensive care and Pain management Prof. Sahar Abdel Baky Mohamed Ahmad 2022
56 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Department of Pathology Dr. Marwa Tammam Ameen Hammam 2022
57 Detection of Epstein-Barr virus Latent Membrane Protein-1 in Pediatric Lymphoma: A Report from South Egypt Cancer Institute Department of Pediatric Oncology Prof. Amany Mohamed Ali Ahmed 2022
58 Pharmacokinetics and pharmacodynamics of 3 doses of oral-mucosal dexmedetomidine gel for sedative premedication in women undergoing modified radical mastectomy for breast cancer Department of Anesthesia, Intensive care and Pain management Dr. Fatma Adel Abd Diab. 2022
59 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
60 Differential regulation of CD45 expression on granulocytes, lymphocytes, and monocytes in COVID-19 Department of Anesthesia, Intensive care and Pain management Mohammed gamal Thabet ahmed 2022